Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Mattiuzzo

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Emerging Infectious Diseases|August 20, 2019
Comparison of Serologic Assays for Middle East Respiratory Syndrome CoronavirusRuth Harvey, Giada Mattiuzzo, Mark Hassall, et al.
Vaccine|November 1, 2019
Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig modelStuart D Dowall, Sarah Kempster, Stephen Findlay-Wilson, et al.
Tropical Medicine and Infectious Disease|August 27, 2021
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation AssayEmma M Bentley, Samuel Richardson, Mariliza Derveni, et al.
Vaccine|February 26, 2026
Workshop report: Improving standardisation of rabies serology methods and proceduresLorraine Marie McElhinney, Luciana Botelho Chaves, Céline Petit, et al.
NPJ Vaccines|October 22, 2019
Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibodyGiada Mattiuzzo, Ivana Knezevic, Mark Hassall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2009
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestrationRavindra K Gupta, Petra Mlcochova, Annegret Pelchen-Matthews, et al.
Antiviral Research|August 10, 2021
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyAdam Leach, F Tudor Ilca, Zulaikha Akbar, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2018
Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus EnvelopesMaha Tijani, Altar M Munis, Christopher Perry, et al.
NPJ Vaccines|October 5, 2020
Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaquesNeil Berry, Sarah Kempster, Claire Ham, et al.
The Journal of Infectious Diseases|February 13, 2023
The Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection on Neutralizing Antibodies: A Nation-wide Cross-sectional AnalysisThomas Althaus, Jordi Landier, Feng Zhu, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Emerging Infectious Diseases|August 20, 2019
Comparison of Serologic Assays for Middle East Respiratory Syndrome CoronavirusRuth Harvey, Giada Mattiuzzo, Mark Hassall, et al.
Vaccine|November 1, 2019
Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig modelStuart D Dowall, Sarah Kempster, Stephen Findlay-Wilson, et al.
Tropical Medicine and Infectious Disease|August 27, 2021
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation AssayEmma M Bentley, Samuel Richardson, Mariliza Derveni, et al.
Vaccine|February 26, 2026
Workshop report: Improving standardisation of rabies serology methods and proceduresLorraine Marie McElhinney, Luciana Botelho Chaves, Céline Petit, et al.
NPJ Vaccines|October 22, 2019
Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibodyGiada Mattiuzzo, Ivana Knezevic, Mark Hassall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2009
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestrationRavindra K Gupta, Petra Mlcochova, Annegret Pelchen-Matthews, et al.
Antiviral Research|August 10, 2021
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyAdam Leach, F Tudor Ilca, Zulaikha Akbar, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2018
Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus EnvelopesMaha Tijani, Altar M Munis, Christopher Perry, et al.
NPJ Vaccines|October 5, 2020
Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaquesNeil Berry, Sarah Kempster, Claire Ham, et al.
The Journal of Infectious Diseases|February 13, 2023
The Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection on Neutralizing Antibodies: A Nation-wide Cross-sectional AnalysisThomas Althaus, Jordi Landier, Feng Zhu, et al.
Pageof 5